Malvinder Singh: Why I Decided to Sell Ranbaxy

June 6 (Bloomberg) -- Malvinder Singh is a member of one of India's most prominent business families. He joins Haslinda Amin on High Flyers to talk about his decision to sell the nation's biggest drugmaker, Ranbaxy, which was founded by his grandfather. He also has firm views about the future of health care in India. (Source: Bloomberg)

Negative Rates Corrosive to Financial System: James Bevan
49:05 - James Bevan, chief investment officer at CCLA Investment, and Gilles Moec, chief European economist at Bank of America Merrill Lynch, discuss the impact of negative interest rates and talk of a potential bond buyback by Deutsche Bank to help ease concerns of investors. They speak on "Bloomberg Surveillance." (Source: Bloomberg)
  • Auto Chip Demand to Jump by $15 Billion: Arm CEO Segars
  • Are Negative Rates a Tax on the Banking System?
  • Allianz CIO Remains Cautious About European Banks